GIGYF1 disruption associates with autism and impaired IGF-1R signaling

Autism spectrum disorder (ASD) represents a group of neurodevelopmental phenotypes with a strong genetic component. An excess of likely gene-disruptive (LGD) mutations in GIGYF1 was implicated in ASD. Here, we report that GIGYF1 is the second-most mutated gene among known ASD high–confidence risk genes. We investigated the inheritance of 46 GIGYF1 LGD variants, including the highly recurrent mutation c.333del:p.L111Rfs*234. Inherited GIGYF1 heterozygous LGD variants were 1.8 times more common than de novo mutations. Among individuals with ASD, cognitive impairments were less likely in those with GIGYF1 LGD variants relative to those with other high-confidence gene mutations. Using a Gigyf1 conditional KO mouse model, we showed that haploinsufficiency in the developing brain led to social impairments without significant cognitive impairments. In contrast, homozygous mice showed more severe social disability as well as cognitive impairments. Gigyf1 deficiency in mice led to a reduction in the number of upper-layer cortical neurons, accompanied by a decrease in proliferation and increase in differentiation of neural progenitor cells. We showed that GIGYF1 regulated the recycling of IGF-1R to the cell surface. KO of GIGYF1 led to a decreased level of IGF-1R on the cell surface, disrupting the IGF-1R/ERK signaling pathway. In summary, our findings show that GIGYF1 is a regulator of IGF-1R recycling. Haploinsufficiency of GIGYF1 was associated with autistic behavior, likely through interference with IGF-1R/ERK signaling pathway.

[1]  R. O'Connor,et al.  Controlled Signaling—Insulin-Like Growth Factor Receptor Endocytosis and Presence at Intracellular Compartments , 2021, Frontiers in Endocrinology.

[2]  Patrick J. Short,et al.  Evidence for 28 genetic disorders discovered by combining healthcare and research data , 2020, Nature.

[3]  Jessica K. Gagnon,et al.  ERK signalling: a master regulator of cell behaviour, life and fate , 2020, Nature Reviews Molecular Cell Biology.

[4]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[5]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[6]  G. Calin,et al.  Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey , 2019, Cells.

[7]  T. Zhou,et al.  Modulation of IGF1R Signaling Pathway by GIGYF1 in High Glucose-Induced SHSY-5Y Cells. , 2018, DNA and cell biology.

[8]  Trygve E Bakken,et al.  Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity , 2018, Nature Genetics.

[9]  Anibal Gutierrez,et al.  SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research , 2018, Neuron.

[10]  B. H. Lo,et al.  Autism Spectrum Disorder , 2018, Journal of paediatrics and child health.

[11]  A. Packer.  Neocortical neurogenesis and the etiology of autism spectrum disorder , 2016, Neuroscience & Biobehavioral Reviews.

[12]  Michael J. McDonald,et al.  Mutation at a distance caused by homopolymeric guanine repeats in Saccharomyces cerevisiae , 2016, Science Advances.

[13]  D. Geschwind,et al.  Advancing the understanding of autism disease mechanisms through genetics , 2016, Nature Medicine.

[14]  C. Munaut,et al.  Dynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4‐MMP) in breast cancer cells , 2016, The FEBS journal.

[15]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[16]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[17]  Kali T. Witherspoon,et al.  Excess of rare, inherited truncating mutations in autism , 2015, Nature Genetics.

[18]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[19]  Yuanyi Feng,et al.  The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation , 2014, eLife.

[20]  Jay Shendure,et al.  Rare-variant extensions of the transmission disequilibrium test: application to autism exome sequence data. , 2014, American journal of human genetics.

[21]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[22]  S. Shi,et al.  Neocortical neurogenesis and neuronal migration , 2013, Wiley interdisciplinary reviews. Developmental biology.

[23]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[24]  Bradley P. Coe,et al.  Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.

[25]  Pavel A. Puzerey,et al.  Disrupted ERK Signaling during Cortical Development Leads to Abnormal Progenitor Proliferation, Neuronal and Network Excitability and Behavior, Modeling Human Neuro-Cardio-Facial-Cutaneous and Related Syndromes , 2012, The Journal of Neuroscience.

[26]  N. Šestan,et al.  Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex , 2012, Development.

[27]  Heng Li,et al.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data , 2011, Bioinform..

[28]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[29]  G. Feng,et al.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction , 2011, Nature.

[30]  C. Lord,et al.  The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors , 2010, Neuron.

[31]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[32]  J. Pouysségur,et al.  ERK implication in cell cycle regulation. , 2007, Biochimica et biophysica acta.

[33]  R. Assoian,et al.  ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. , 2007, Molecular biology of the cell.

[34]  Robert J. Smith,et al.  The adapter protein GRB10 is an endogenous negative regulator of insulin-like growth factor signaling. , 2005, Endocrinology.

[35]  R. Ober,et al.  From sorting endosomes to exocytosis: association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling. , 2005, Molecular biology of the cell.

[36]  J. McCubrey,et al.  Synergy between PI3K/Akt and Raf/MEK/ERK Pathways in IGF-1R Mediated Cell Cycle Progression and Prevention of Apoptosis in Hematopoietic Cells , 2004, Cell cycle.

[37]  F. Giorgino,et al.  Two Novel Proteins That Are Linked to Insulin-like Growth Factor (IGF-I) Receptors by the Grb10 Adapter and Modulate IGF-I Signaling* , 2003, Journal of Biological Chemistry.